4baseCare has secured CAP accreditation

The accreditation will allow for more accessible and affordable healthcare services across the Middle East.

4baseCare, a leader in precision oncology, has obtained CAP (College of American Pathologists) accreditation for its genomics lab at Dubai Science Park.

This lab was established in partnership with Innovate Life Sciences Fz-LLC, further solidifying the commitment to providing advanced cancer care in the region.

This accreditation ensures that cancer patients in the UAE now have access to world-class genomic profiling locally, meeting the highest international standards of quality and accuracy.

Dr. Sudharshan Elangovan, VP of Global Operations, 4baseCare said: “Our mission is to democratize access to high-quality genomic insights, empowering oncologists with cutting-edge molecular data to drive better patient outcomes”.

By securing CAP accreditation, 4baseCare reaffirms its commitment to advancing cancer care through data-driven, personalized treatment decisions. The Dubai-based facility bridges a critical gap in precision oncology, eliminating the need for patients to seek genomic testing solutions outside of the UAE.

Syed Hussaini, General Manager, Innovate Life Sciences, further commented on the achievement, adding, “This achievement underscores our dedication to quality and innovation, strengthening our mission to make precision medicine more accessible and affordable across the Middle East and beyond.”